State AGs Sway Judge Against Homeopathic Firm's False Ad Settlement
Executive Summary
A US district court judge says a settlement over false marketing claims by homeopathic maker Similasan would only benefit the two plaintiffs named in the case and their lawyer, and not a class of unnamed consumers who also purchased the firm’s eye, ear, stress and sleep-aid products.
You may also be interested in...
Homeopathic Advertising Offers Slim Target For FTC Scrutiny – Industry
OTC homeopathic brands rely largely on word-of-mouth advertising from consumers’ friends and family members about their products’ safety and efficacy, stakeholders say at an FTC workshop. Consumers trust homeopathic OTCs even if they don’t understand products’ formulations, they say.
Cosmetics Industry Awaits FDA’s Allergen List While Working To Inform GMP Rulemaking
The Independent Beauty Association does not yet have insight into what ingredients will be listed in the US FDA’s proposed rulemaking for cosmetic allergen labeling – due by 29 June – but is optimistic the agency will consult industry when it comes to setting the compliance timeline. Meanwhile, industry stakeholders are pushing for international harmonization in the agency’s cosmetic GMPs rulemaking.
AI Advancing Quickly, But Same FTC, IP Rules Apply – Attorney
Artificial intelligence opportunities are on the rise for marketers, including in the beauty and personal-care sectors. Reed Smith partner Stacy Marcus offers advice on staying compliant with US consumer protection and copyright laws in this rapidly changing world.